Regeneron Pharmaceuticals, Inc.
MX ˙ BMV ˙ US75886F1075
SecurityMX:REGN / Regeneron Pharmaceuticals, Inc.
InstitutionCommerzbank Aktiengesellschaft /fi
Latest Disclosed Ownership539 shares
Latest Disclosed Value $ 416
Commerzbank Aktiengesellschaft /fi ownership in REGN / Regeneron Pharmaceuticals, Inc.

On May 7, 2026 - Commerzbank Aktiengesellschaft /fi filed a 13F-HR form disclosing ownership of 539 shares of Regeneron Pharmaceuticals, Inc. (MX:REGN) valued at $416 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 578 shares of Regeneron Pharmaceuticals, Inc..

Commerzbank Aktiengesellschaft /fi has a history of taking positions in derivatives of the underlying security (REGN) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:REGN / Regeneron Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 539 -39 -6.75 0 0.0087
2026-02-05 2025-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 578 0 0.00 0 0.0091
2025-10-31 2025-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 578 -23 -3.83 0 0.0068
2025-07-24 2025-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 601 0 0.00 0 0.0072
2025-05-02 2025-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 601 0 0.00 0 0.0089
2025-02-06 2024-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 601 199 49.50 0 0.0102
2024-10-22 2024-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 402 171 74.03 0 0.0113
2024-07-22 2024-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 231 231 0 0.0080
2024-10-03 2020-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 0 -6,287 -100.00 0 -100.00
2020-07-21 2020-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -6,287 0
2024-10-03 2020-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 6,287 -3,435 -35.33 3 0.00 0.1372
2020-04-29 2020-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 6,287 -3,435 3,070 0.1881
2024-10-03 2019-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 9,722 -19,989 -67.28 4 -62.50 0.0355
2020-01-17 2019-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 9,722 -19,989 3,650 0.0383
2024-10-03 2019-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 29,711 2,685 9.93 8 0.00 0.0631
2019-10-17 2019-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 29,711 2,685 8,242 0.0670
2024-10-03 2019-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 27,026 -3,808 -12.35 8 -33.33 0.0670
2019-07-23 2019-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 27,026 -3,808 8,459 0.0596
2024-10-03 2019-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 30,834 2,880 10.30 13 20.00 0.1155
2019-05-13 2019-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 30,834 2,880 12,661 0.1279
2024-10-03 2018-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 27,954 400 1.45 10 -9.09 0.1067
2019-02-06 2018-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 27,954 400 10,441 0.1137
2024-10-04 2018-09-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 27,554 11,776 74.64 11 120.00 0.0965
2018-11-13 2018-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 27,554 11,776 11,133 0.1052
2024-10-04 2018-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 15,778 -23,873 -60.21 5 -61.54 0.0516
2024-10-04 2018-06-30 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 15,778 -23,873 5 0.0516
2018-08-10 2018-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 15,778 -23,873 5,443 0.0556
2024-10-04 2018-03-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 39,651 3,363 9.27 14 0.00 0.1404
2018-05-01 2018-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 39,651 3,363 13,654 0.1520
2024-10-04 2017-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 36,288 -5,656 -13.48 14 -99.93 0.1565
2018-01-26 2017-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 36,288 -5,656 13,643 0.1692
2017-11-13 2017-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 41,944 15,395 57.99 18,754 43.83 0.2470
2017-08-09 2017-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 26,549 6,229 30.65 13,039 65.60 0.2189
2017-05-01 2017-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 20,320 -4,109 -16.82 7,874 -12.20 0.1166
2017-02-07 2016-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 24,429 1,847 8.18 8,968 -1.21 0.1319
2016-11-10 2016-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 22,582 -172 -0.76 9,078 14.25 0.1463
2016-08-01 2016-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 22,754 -582 -2.49 7,946 -5.53 0.0534
2016-05-10 2016-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 23,336 -27,626 -54.21 8,411 -69.60 0.0705
2016-02-11 2015-12-31 13F/A-1 REGENERON PHARMACEUTICALS COM 75886F107 50,962 6,996 15.91 27,666 35.29 0.2128
2016-02-05 2015-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 50,962 27,666
2015-10-29 2015-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 43,966 -22,413 -33.77 20,450 -39.61 0.1535
2015-08-10 2015-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 66,379 3,298 5.23 33,862 18.90 0.1776
2015-05-01 2015-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 63,081 63,081 0.00 28,480 0.1709
2015-02-05 2014-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 0 -74,061 -100.00 0 -100.00
2014-11-13 2014-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 74,061 3,112 4.39 26,701 33.23 0.1077
2014-08-12 2014-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 70,949 15,520 28.00 20,041 20.41 0.1024
2014-05-14 2014-03-31 13F REGENERON PHARMACEUTICALS COM 75886F107 55,429 5,976 12.08 16,644 16.62 0.0717
2014-02-13 2013-12-31 13F REGENERON PHARMACEUTICALS COM 75886F107 49,453 -6,400 -11.46 14,272 -18.33 0.0699
2013-11-14 2013-09-30 13F REGENERON PHARMACEUTICALS COM 75886F107 55,853 8,593 18.18 17,475 64.42 0.0874
2013-07-23 2013-06-30 13F REGENERON PHARMACEUTICALS COM 75886F107 47,260 47,260 10,628 0.0468
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-10-03 2019-09-30 13F/A REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-10-17 2019-09-30 13F REGENERON PHARMACEUTICALS CALL Call 0 0 n/a n/a n/a
2024-10-03 2019-06-30 13F/A REGENERON PHARMACEUTICALS COM Call 38,800 29.33 1 n/a n/a n/a
2019-07-23 2019-06-30 13F REGENERON PHARMACEUTICALS CALL Call 38,800 12,144 n/a n/a n/a
2024-10-04 2018-03-31 13F/A REGENERON PHARMACEUTICALS COM Call 0 -100.00 0 n/a n/a n/a
2024-10-04 2017-12-31 13F/A REGENERON PHARMACEUTICALS COM Call 30,000 3,650.00 0 -100.00 n/a n/a n/a
2017-11-13 2017-09-30 13F REGENERON PHARMACEUTICALS CALL Call 800 358 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2024-10-03 2019-09-30 13F/A REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2019-10-17 2019-09-30 13F REGENERON PHARMACEUTICALS PUT Put 0 0 n/a n/a n/a
2024-10-03 2019-06-30 13F/A REGENERON PHARMACEUTICALS COM Put 15,000 0 n/a n/a n/a
2019-07-23 2019-06-30 13F REGENERON PHARMACEUTICALS PUT Put 15,000 4,695 n/a n/a n/a
2024-10-03 2019-03-31 13F/A REGENERON PHARMACEUTICALS COM Put 0 -100.00 0 n/a n/a n/a
2024-10-03 2018-12-31 13F/A REGENERON PHARMACEUTICALS COM Put 37,700 0.00 0 n/a n/a n/a
2024-10-04 2018-09-30 13F/A REGENERON PHARMACEUTICALS COM Put 37,700 89.45 0 n/a n/a n/a
2024-10-04 2018-06-30 13F/A REGENERON PHARMACEUTICALS COM Put 19,900 0 n/a n/a n/a
2024-10-04 2018-06-30 13F/A REGENERON PHARMACEUTICALS COM Put 19,900 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.